CCM
ABBV icon

Coldstream Capital Management’s AbbVie ABBV Stock Holding History

Coldstream Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-400
Closed -$23K – 196
2014
Q2 		$23K Buy
+400
New +$21K 0.01% 209

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Coldstream Capital Management's ABBV Position: Q1 2026 in Review

Coldstream Capital Management increased its AbbVie (ABBV) stake by 0.99% in Q1 2026, buying an estimated $161K and bringing the position to 74,217 shares worth $16.1M. The position accounts for 0.2% of the portfolio, ranked #66.

Coldstream Capital Management first reported a position in ABBV in Q2 2013 and has held it in 51 quarters since. The position peaked at $16.8M in Q4 2025. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Coldstream Capital Management held 74,217 shares of AbbVie worth $16.1M as of Q1 2026.
  • Coldstream Capital Management bought 727 AbbVie shares in Q1 2026, an estimated $161K.
  • AbbVie made up 0.2% of Coldstream Capital Management's portfolio in Q1 2026, its #66 holding.
  • Coldstream Capital Management first reported a position in AbbVie in Q2 2013 and has held it in 51 quarters since.
  • Coldstream Capital Management's AbbVie position peaked at $16.8M in Q4 2025.
  • 4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Coldstream Capital Management's 13F filing for Q1 2026, filed 8 May 2026.